A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
NCT01986738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9
Last updated 2017-03-03
Summary
This is a study to assess the motion of pancreatic tumors during radiation therapy using Computed Tomography (CT) Scans and an Active Breathing Control (ABC) Device.
Conditions
Interventions
- RADIATION
-
Standard Radiation Therapy
Radiotherapy will be planned and delivered according to institutional standard of care.
- DEVICE
-
Active Breathing Control Device (ABC)
- DEVICE
-
Computed Tomography Scan (CT)
Sponsors & Collaborators
-
University of Michigan Rogel Cancer Center
lead OTHER
Principal Investigators
-
Kyle Cuneo, M.D. · University of Michigan Rogel Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
NCT00844649 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer
NCT02873598 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
NCT00761345 ·Status: COMPLETED ·Phase: PHASE1
-
Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)
NCT05191940 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
NCT00707278 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer
NCT00889187 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
NCT00176735 ·Status: TERMINATED ·Phase: NA
-
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
NCT03492671 ·Status: RECRUITING ·Phase: PHASE2
-
Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer
NCT04289792 ·Status: UNKNOWN ·Phase: PHASE2
-
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
NCT01693276 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer
NCT00438256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
NCT01964534 ·Status: UNKNOWN ·Phase: PHASE2
-
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
NCT03257033 ·Status: RECRUITING ·Phase: PHASE3
-
Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer
NCT00460174 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer
NCT04894643 ·Status: RECRUITING ·Phase: NA
-
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
NCT01434550 ·Status: WITHDRAWN ·Phase: NA
-
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
NCT04975516 ·Status: TERMINATED ·Phase: PHASE2
-
Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B
NCT03778879 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
NCT06453486 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer
NCT02347618 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
NCT01360593 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Therapy for Unresectable Cancer (CA) of Pancreas
NCT00685763 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors
NCT06081322 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
NCT00025168 ·Status: COMPLETED ·Phase: PHASE2
-
Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer
NCT00878657 ·Status: TERMINATED ·Phase: PHASE1